Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]

Detalles Bibliográficos
Autores principales: Choueiri, T.K., Larkin, J., Pal, S., Motzer, R.J., Rini, B.I., Venugopal, B., Alekseev, B., Miyake, H., Gravis, G., Bilen, M.A., Hariharan, S., Chudnovsky, A., Ching, K.A., Mu, X.J., Mariani, M., Robbins, P.B., Huang, B., di Pietro, A., Albiges, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411062/
https://www.ncbi.nlm.nih.gov/pubmed/34474809
http://dx.doi.org/10.1016/j.esmoop.2021.100177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411062/
https://www.ncbi.nlm.nih.gov/pubmed/34474809
http://dx.doi.org/10.1016/j.esmoop.2021.100177

Ejemplares similares